drugset / Trial / NCT05156437

Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL)

NCT05156437

Phase 4 Terminated 5 enrolled West Virginia University
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the safety and compliance of initial intravenous (IV) antibiotics followed by oral antibiotic therapy following uncomplicated IVDA endocarditis. Endocarditis has a high rate of sickness and death, involves a long hospitalization and a long-term use of IV antibiotics necessitating six (6) weeks of in-patient hospital stay, and comes with a high cost.

Timeline

Start
2022-03-16
Primary completion
2024-10-31
Completion
2024-10-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified Oral
Subject Ampicillin Unknown Intravenous
Subject CEPHALEXIN ANHYDROUS Small molecule Oral
Subject Cefepime Small molecule Intravenous
Subject Ceftaroline Other / unclassified Intravenous
Subject Ceftriaxone Other / unclassified Intravenous
Subject Daptomycin Other / unclassified Intravenous
Subject Dicloxacillin Small molecule Oral
Subject Levofloxacin Small molecule Oral
Subject Linezolid Other / unclassified Oral
Subject Rifampin Small molecule Oral
Subject Vancomycin Other / unclassified Intravenous
Subject oxacillin Small molecule Intravenous

Indications